BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18503700)

  • 1. Serum pro-hepcidin as an indicator of iron status in dialysis patients.
    Tsuchihashi D; Abe T; Komaba H; Fujii H; Hamada Y; Nii-Kono T; Tanaka M; Fukagawa M
    Ther Apher Dial; 2008 Jun; 12(3):226-31. PubMed ID: 18503700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs].
    Chełchowska M; Lewandowski L; Ambroszkiewicz J; Swiatek E; Gajewska J; Ołtarzewski M; Laskowska-Klita T
    Przegl Lek; 2008; 65(10):474-8. PubMed ID: 19189526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.
    Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M
    Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
    Malyszko J; Malyszko JS; Mysliwiec M
    Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
    Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
    Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
    Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
    Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients.
    Arabul M; Gullulu M; Yilmaz Y; Eren MA; Baran B; Gul CB; Kocamaz G; Dilek K
    Med Sci Monit; 2009 Nov; 15(11):CR583-7. PubMed ID: 19865058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI).
    Sasu BJ; Li H; Rose MJ; Arvedson TL; Doellgast G; Molineux G
    Blood Cells Mol Dis; 2010 Oct; 45(3):238-45. PubMed ID: 20800515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum pro-hepcidin levels and relationships with iron parameters in healthy preterm and term newborns.
    Tiker F; Celik B; Tarcan A; Kilicdag H; Ozbek N; Gurakan B
    Pediatr Hematol Oncol; 2006 Jun; 23(4):293-7. PubMed ID: 16621770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal pro-hepcidin at term correlates with cord blood pro-hepcidin at birth.
    Ervasti M; Sankilampi U; Luukkonen S; Heinonen S; Punnonen K
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):161-5. PubMed ID: 19740590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pro-hepcidin, its relation with indicators of iron metabolism and of inflammation in patients hemodialyzed treated or not with recombinant erythropoietin].
    Barrios Y; Espinoza M; Barón MA
    Nutr Hosp; 2010; 25(4):555-60. PubMed ID: 20694291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-hepcidin and iron metabolism parameters in multi-time blood donors.
    Boinska J; Zekanowska E; Kwapisz J
    Int J Lab Hematol; 2010 Oct; 32(5):483-90. PubMed ID: 19968722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does hepcidin affect erythropoiesis in hemodialysis patients?
    Eleftheriadis T; Kartsios C; Liakopoulos V; Antoniadi G; Ditsa M; Papadopoulos C; Anifandis G; Skirta A; Markala D; Stefanidis I
    Acta Haematol; 2006; 116(4):238-44. PubMed ID: 17119323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin is not a marker of chronic inflammation in atherosclerosis.
    Oğuz A; Uzunlulu M; Hekim N
    Anadolu Kardiyol Derg; 2006 Sep; 6(3):239-42. PubMed ID: 16943108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.
    Eleftheriadis T; Liakopoulos V; Antoniadi G; Kartsios C; Stefanidis I
    Semin Dial; 2009; 22(1):70-7. PubMed ID: 19250447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.
    Kuragano T; Shimonaka Y; Kida A; Furuta M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
    Am J Nephrol; 2010; 31(6):534-40. PubMed ID: 20484891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of and correspondence among different hepcidin forms in blood and urine and their relationships to iron status in healthy, male Guatemalan volunteers observed over 9 weeks.
    Schuemann K; Solomons NW; Laarakkers CM; Romero-Abal ME; Kroll S; Weiss G; Swinkels DW
    Ann Nutr Metab; 2011; 58(2):158-66. PubMed ID: 21654163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.